What is callikrein?

calylikrein is a term used for a subgroup of enzymes referred to as serine proteases. Serine proteases are responsible for cutting peptide bonds found in different proteins. Peptide bonds are chemical bonds created between two molecules, leading to what is called amid. Amid is an organic compound found in items such as some solvents and medicines. When this enzyme was first discovered, it was assumed that it was made and unique to the pancreas. As the science progressed, the Kallikrein enzyme was found in saliva, urine and human blood. Since then, these enzymes have been found in other animals, including, but not only on mammals. Kinin is a type of polypeptide or an amino acid chain. Amino acids are responsible for protein production. Kininogens are known as precursors for Kinin. The primary task of plasmin is to dissolve the blood clots known as fibrin blood clots. These types of blood clots are responsible for creating rattles over the wound when youIt begins to heal. Plasminogen is a predecessor of plasmin and is located in a plasma or in a liquid part of the blood.

drug researchers actively study the enzyme callikrein because timely evidence suggests that changes in this family of enzymes could lead to health conditions such as cancer for some time. Some callikrein genes are already used as prostate cancer markers because these enzymes have been found to be increased when these tumors are present. Another study could lead to an earlier detection of many types of cancer, giving it a more positive prognosis for those who give this diagnosis a lot running.

Biomarkers are any substances that can be injected or otherwise introduced into the body to explore the function of body organs or systems. These biomarkers can also be used to monitor the disease progression. For these reasons, the enzyme Kallikrein is studied not only by scientists,But also pharmaceutical companies. As the research begins to propose special usefulness for this family of enzymes, pharmaceutical companies hire their own scientists to examine the pharmaceutical consequences of these medical advances.